These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase. Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571 [TBL] [Abstract][Full Text] [Related]
4. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer. Roh JL; Park JY; Kim EH; Jang HJ; Kwon M Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904 [TBL] [Abstract][Full Text] [Related]
5. Mitochondrial activation by inhibition of PDKII suppresses HIF1a signaling and angiogenesis in cancer. Sutendra G; Dromparis P; Kinnaird A; Stenson TH; Haromy A; Parker JM; McMurtry MS; Michelakis ED Oncogene; 2013 Mar; 32(13):1638-50. PubMed ID: 22614004 [TBL] [Abstract][Full Text] [Related]
6. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells. Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267 [TBL] [Abstract][Full Text] [Related]
10. Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism. Ai Z; Lu Y; Qiu S; Fan Z Cancer Lett; 2016 Apr; 373(1):36-44. PubMed ID: 26801746 [TBL] [Abstract][Full Text] [Related]
11. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation. Kumar A; Kant S; Singh SM Toxicol Appl Pharmacol; 2013 Nov; 273(1):196-208. PubMed ID: 24051182 [TBL] [Abstract][Full Text] [Related]
12. Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming. Jin J; Qiu S; Wang P; Liang X; Huang F; Wu H; Zhang B; Zhang W; Tian X; Xu R; Shi H; Wu X J Exp Clin Cancer Res; 2019 Aug; 38(1):377. PubMed ID: 31455352 [TBL] [Abstract][Full Text] [Related]
13. Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC. Stockwin LH; Yu SX; Borgel S; Hancock C; Wolfe TL; Phillips LR; Hollingshead MG; Newton DL Int J Cancer; 2010 Dec; 127(11):2510-9. PubMed ID: 20533281 [TBL] [Abstract][Full Text] [Related]
14. Pyruvate dehydrogenase kinase regulates hepatitis C virus replication. Jung GS; Jeon JH; Choi YK; Jang SY; Park SY; Kim SW; Byun JK; Kim MK; Lee S; Shin EC; Lee IK; Kang YN; Park KG Sci Rep; 2016 Jul; 6():30846. PubMed ID: 27471054 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of pyruvate dehydrogenase kinase supports dichloroacetate as a candidate for cutaneous melanoma therapy. Pópulo H; Caldas R; Lopes JM; Pardal J; Máximo V; Soares P Expert Opin Ther Targets; 2015 Jun; 19(6):733-45. PubMed ID: 25976231 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factor-1 up-regulates the expression of Toll-like receptor 4 in pancreatic cancer cells under hypoxic conditions. Fan P; Zhang JJ; Wang B; Wu HQ; Zhou SX; Wang CY; Zhang JH; Tian Y; Wu HS Pancreatology; 2012; 12(2):170-8. PubMed ID: 22487528 [TBL] [Abstract][Full Text] [Related]
18. Sensitization of metformin-cytotoxicity by dichloroacetate via reprogramming glucose metabolism in cancer cells. Choi YW; Lim IK Cancer Lett; 2014 May; 346(2):300-8. PubMed ID: 24480191 [TBL] [Abstract][Full Text] [Related]
19. HIF-1α stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells. Comito G; Calvani M; Giannoni E; Bianchini F; Calorini L; Torre E; Migliore C; Giordano S; Chiarugi P Free Radic Biol Med; 2011 Aug; 51(4):893-904. PubMed ID: 21703345 [TBL] [Abstract][Full Text] [Related]
20. Sphingosine kinase 1 pathway is involved in melatonin-induced HIF-1α inactivation in hypoxic PC-3 prostate cancer cells. Cho SY; Lee HJ; Jeong SJ; Lee HJ; Kim HS; Chen CY; Lee EO; Kim SH J Pineal Res; 2011 Aug; 51(1):87-93. PubMed ID: 21392092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]